Study to Evaluate an Influenza Vaccine Candidate

NCT00540228 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1006
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline